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Abstract 
Calmodulin (CaM) is a ubiquitous cytosolic Ca2+-binding protein able to bind and regulate hundreds 
of different proteins.  It consists of two globular domains joined by a flexible central linker region. Each 
one of these domains contains two EF hand pairs capable of binding to Ca2+.  Upon Ca2+ binding CaM 
undergoes a conformational change exposing hydrophobic patches that interact with its intracellular 
target proteins. CaM is able to bind to target proteins in the Ca2+-replete and Ca2+-deplete forms. To 
study the Ca2+-dependent/independent properties of binding and activation of target proteins by CaM, 
CaM constructs with Ca2+ binding disrupting mutations of Asp to Ala at position 1 of each EF hand 
have been used. One target protein of CaM is nitric oxide synthase (NOS), which catalyzes the 
production of nitric oxide (NO). At elevated Ca2+ concentrations, CaM binds to neuronal NOS (nNOS) 
and endothelial NOS (eNOS), making them the Ca2+-dependent NOS enzymes. In contrast, inducible 
NOS (iNOS) is transcriptionally regulated in vivo and binds to CaM at basal levels of Ca2+. Here we 
report the NMR backbone and sidechain resonance assignments of C-lobe Ca2+-replete and deplete 
CaM12, N-lobe Ca2+-replete and deplete CaM34, CaM1234 in the absence of Ca2+ and N-lobe Ca2+-replete 
CaM34 with the iNOS CaM-binding domain peptide. 
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Calmodulin (CaM) is a ubiquitous cytosolic Ca2+-binding protein that is able to bind and regulate 
hundreds of different proteins (Ikura and Ames 2006).  CaM consists of two globular domains joined by 
a flexible central linker region. Each one of these domains contains two EF hand pairs capable of 
binding to Ca2+. Each EF hand consists of a helix-loop-helix structural element, with the 12 residues 
long loop being rich in aspartates and glutamates. Upon Ca2+ binding to CaM’s EF hands, CaM 
undergoes a conformational change that exposes hydrophobic patches on each domain thereby allowing 
CaM to associate with its intracellular target proteins. The central linker’s flexibility allows it to adapt 
its conformation to optimally associate with its intracellular targets (Persechini and Kretsinger 1988). 
CaM is able to bind to target proteins in the Ca2+-replete and Ca2+-deplete forms.  
To study the Ca2+-dependent/independent properties of binding and activation of target proteins by 
CaM, numerous studies use a series of CaM mutants that involves conversion of Asp to Ala at position 
1 of each EF hand (Geiser et al. 1991, Xia et al. 1998, Xiong et al. 2010). Changing the aspartate residue 
at position 1 of the EF hand loop of CaM inactivates the EF hand toward Ca2+ binding. These CaM 
proteins are defective in Ca2+ binding in either the N-terminal lobe EF hands (CaM12; CaM D20A and 
D56A mutations), the C-terminal lobe EF hands (CaM34; CaM D93A and D129A), or all four of its 
Ca2+-binding EF hands (CaM1234; mutations at D20A, D56A, D93A and D129A inclusive). A recent 
study by Xiong et al. (2010) has shown that although conversion of D93 and D129 to Ala effectively 
inhibits Ca2+ binding to EF hands III and IV, the mutations may cause some structural perturbations in 
the C-domain. This suggests that the Ca2+-deficient CaM mutants may adopt a different structure 
compared to that of the apo N- and C-domains of CaM. 
One of the target proteins bound and regulated by CaM is the nitric oxide synthase (NOS) enzymes. 
These enzymes catalyze the production of nitric oxide (•NO) that acts as a secondary inter- and 
intracellular messenger involved in many physiological processes (Alderton et al. 2001). Three NOS 
isozymes are found in mammals: neuronal NOS (nNOS, NOS I), endothelial NOS (eNOS, NOS III), 
and inducible (iNOS, NOS II). The NOS enzymes are homodimeric with each monomer containing an 
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N-terminal oxygenase domain and a C-terminal reductase domain, connected by a CaM binding domain 
(Alderton et al. 2001, Daff 2010). At elevated Ca2+ concentrations, CaM binds to and activates the 
cNOS enzymes, nNOS and eNOS, making them Ca2+-dependent NOS enzymes. In contrast, iNOS is 
transcriptionally regulated in vivo by cytokines and binds to CaM at basal levels of Ca2+. The Ca2+-
deficient mutant CaM proteins can be used to allow for a specific structural investigation of Ca2+-
dependent/independent activation and binding of CaM to iNOS. Previous to this study the solution 
structures of apoCaM, holoCaM and holoCaM with the iNOS CaM-binding domain peptide have been 
determined (Kuboniwa et al. 1995, Piazza et al. 2012). 
Here we present the NMR resonance assignments of C-lobe Ca2+-replete and deplete CaM12, N-lobe 
Ca2+-replete and deplete CaM34, CaM1234 in the absence of Ca2+ and N-lobe Ca2+-replete CaM34 with the 
iNOS CaM-binding domain peptide. These assignments can be used to solve the solution structures of 
these Ca2+-deficient CaM mutants and compare them to known structures of apoCaM. Furthermore, 
these assignments can be used as a foundation for further NMR studies of Ca2+-deficient CaM mutants 
interacting with various target peptides, such as the NOS peptides. 
Methods and experiments 
Expression and purification of CaM1234, CaM12 and CaM34 
Plasmids coding for CaM12, CaM34 and CaM1234 were subcloned into the kanamycin resistant vector 
pET9dCaM. The human iNOS (RREIPLKVLVKAVLFACMLMRK, 22 residues corresponding to 
residues 510-531 from the full length iNOS protein) peptide was synthesized and purchased from 
Sigma. CaM12, CaM34 and CaM1234 were expressed in E. coli BL21DE3 competent cells and grown in 
M9 media (11.03 g/L Na2HPO4·7H2O, 3.0 g/L KH2PO4, 0.5 g/L NaCl, 2 mM MgSO4, 0.1 mM CaCl2, 5 
mg/mL Thiamine, 100 μg/mL kanamycin) containing 2 g/L 13C-glucose and 1 g/L 15NH4Cl at 37°C. 
Protein expression was induced at an OD600nm of 0.6 with 500 μM isopropyl-β-D-thiogalactopyranoside 
(IPTG) and harvested after 4 h by centrifugation at 6000 x g at 4°C for 5 minutes. Cells were 
resuspended in 4 volumes of 50 mM MOPS, 100 mM KCl, 1 mM EDTA, 1 mM DTT, pH 7.5 and lysed 
by homogenization using an Avestin EmulsiFlex-C5 homogenizer (Ottawa, ON). The lysate was then 
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clarified by centrifugation at 48,000 x g for 30 minutes at 4°C. To the clarified supernatant, CaCl2 was 
added to a concentration of 5 mM in order to saturate CaM with Ca2+ and induce the exposure of 
hydrophobic patches in the N- and C-domains of CaM to allow CaM to interact with the resin. This 
Ca2+-saturated supernatant was then loaded onto 20 mL of phenyl sepharose 6 fast flow highly-
substituted resin (GE Healthcare Bio-Sciences, Baie d’Urfe, PQ) in a 1 cm x 30 cm Econo-column (Bio-
Rad Laboratories, Mississauga, ON) equilibrated with 50 mM Tris-HCl, 1 mM CaCl2, pH 7.5 @ 4°C. 
After the Ca2+-saturated solution was loaded; the resin was washed with 100 mL of the above. The resin 
was subsequently washed with 80 mL of 50 mM Tris-HCl, 500 mM NaCl, 1 mM CaCl2, pH 7.5 @ 4°C 
to remove any non-specific proteins that were interacting with the resin. The resin was finally washed 
with 50 mL of 50 mM Tris-HCl, 1 mM CaCl2, pH 7.5 to remove NaCl from the resin. CaM was then 
eluted from the phenyl sepharose resin with approximately 30 mL of 10 mM Tris-HCl, 10 mM EDTA, 
pH 7.5 @ 4°C and 2 mL fractions were collected. Fractions were then scanned from 325 to 250 nm on a 
Varian Cary UV–visible Spectrophotometer (Varian, Mississauga, ON). Fractions displaying the 
characteristic absorbance peaks of CaM at 277 nm (for tyrosine residues) and 269, 265, 259, and 253 
nm (for phenylalanine residues) were pooled and concentrated to 2 mL sample sizes. The samples were 
then run through a HiLoad 16/600 Superdex 75 column (GE Healthcare Bio-Sciences, Baie d’Urfe, PQ) 
connected to the Äkta design system (GE Healthcare Bio-Sciences, Baie d’Urfe, PQ) using buffer 
consisting of 50 mM Tris-HCl, 0.5 mM EDTA, pH 7.5. Fractions eluted at the characteristic time point 
for proteins of CaM’s size were collected. Isolation and purity of the CaM proteins (148 residues) were 
confirmed by ESI-MS and SDS-PAGE. 
NMR spectroscopy 
The Ca2+ saturated samples were prepared for NMR experiments via a buffer exchange into 100 mM 
KCl, 10 mM CaCl2, 0.2 mM NaN3, 90% H2O/10% 2H2O at pH 6.0 using a YM10 centrifugal filter 
device (Millipore Corp., Billerica, USA). The Ca2+ free samples were prepared for NMR experiments 
via a buffer exchange into 100 mM KCl, 0.5 mM EDTA, 0.2 mM NaN3, 90% H2O/10% 2H2O at pH 6.0 
using a YM10 centrifugal filter device. All NMR samples contained at least 1 mM CaM12, CaM34 and 
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CaM1234 in a total volume of 500 μL. The samples were transferred into 5 mm NMR sample tubes and 
stored at 4oC until required for NMR experiments. NMR experiments on the complexes were conducted 
on samples titrated with iNOS peptide to saturation in a 1:1 CaM:peptide ratio. Complex formation was 
monitored after each addition by acquisition of a 1H-15N heteronuclear single-quantum coherence 
(HSQC) spectrum.  
NMR spectra were recorded at 298K on Bruker 600 and 700 MHz DRX spectrometers equipped with 
XYZ-gradients triple-resonance probes (Bruker, Billerica, MA, USA). Specific NMR resonance 
assignments were achieved using [1H-15N]-HSQC, HNCA, CBCA(CO)NH, (H)CCH-TOCSY, 
HC(C)H-TOCSY, 13C-NOESY-HSQC and 15N-NOESY-HSQC experiments, while using the NMR 
resonance assignments of the wild type CaM as a starting point for the un-mutated lobes of the Ca2+-
deficient CaM mutants. Spectra were analyzed using the program CARA (Keller 2005). 
Assignments and data deposition 
Table 1 shows the list of Ca2+-deficient CaM mutants used in this study, the completeness of their 
chemical shift assignments and their BMRB accession identification codes. For apoCaM12 almost all 
non-proline backbone resonances were assigned (97.9%) with the exception of A1, D2 and F92. The 
chemical shift assignment of apoCaM12 was deposited in the BMRB database under accession number 
26682. ApoCaM34 had most non-proline backbone resonances assigned (94.5%) with the exception of 
residues A1, D2, R90, V91, F92, I100, V136 and E140. The chemical shift assignment of apoCaM34 
was deposited in the BMRB database under accession number 26683. For the Ca2+CaM12 construct 
97.9% of non-proline backbone resonances were assigned excluding A1, D2 and A57. The chemical 
shift assignment of Ca2+CaM12 was deposited in the BMRB database under accession number 26685. 
For Ca2+CaM34 all non-proline backbone resonances were assigned (91.8%) with the exception of A1, 
D2, E67, M72, R86, R90, V91, F92, A93, I100, V136 and E140. The chemical shift assignment of 
Ca2+CaM34 was deposited in the BMRB database under accession number 26686. 
Figure 1A shows the [1H,15N]- HSQC spectrum of the CaM1234. Almost complete amide resonance 
assignment for apoCaM1234 was achieved. Overall 97.2% of all 1HN, 15N resonances were assigned with 
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the exception of the first residue A1, and D2, R90, I100 and the two Proline residues. Among the 
backbone resonances, 96.6% of Cα, 90.5% of Cβ, and 96.6% of Hα were assigned. In total, 84.0% of 
sidechain 1H resonances, with 91.9% of Hβ resonances were assigned. Overall, the [1H, 15N] HSQC 
spectrum exhibits good resolution and well dispersed signals, indicating a uniform and folded protein 
structure. Chemical shift changes induced by the 4 EF hand mutations appear for the amides throughout 
all 4 of the Ca2+-binding EF hands, with the greatest differences occurring for the amides in the center 
of the Ca2+-binding loop (Fig. 2A). The amide resonances of the loop region between EF hands I and II 
and the linker region between EF hands II and III show little chemical shift differences with each other 
suggesting a similar structure for both proteins. The chemical shift assignment of apoCaM1234 was 
deposited in the BMRB database under accession number 26681. 
Figure 1B shows the [1H,15N]- HSQC spectrum of Ca2+CaM34 bound to the iNOS CaM binding 
domain peptide. Almost complete amide resonance assignment was achieved. Overall 98.6% of all 1HN, 
15N resonances were assigned with the exception of the first A1 residue, I100 and the two Proline 
residues. Among the backbone resonances, 97.3% of Cα, 96.4% of Cβ, and 97.3% of Hα were assigned. 
In total 89.4% of sidechain 1H resonances, with 96.4% of Hβ of resonances were assigned. Overall, the 
[1H, 15N] HSQC spectrum exhibits good resolution and well dispersed signals, indicating a uniform and 
folded protein structure. Chemical shift changes induced by the C-lobe EF hand mutations appear for 
the amides in the C-domain, specifically the amides of residues that participate in coordinating the Ca2+ 
ion in EF hands III and IV, with the greatest differences occurring for the amides in the center of the 
Ca2+-binding loop (Fig. 2D). The amide resonances of the N-lobe show little chemical shift differences 
suggesting a similar structure of the N-lobe bound to iNOS for both complexes. The chemical shift 
assignment of CaM34 with iNOS was deposited in the BMRB database under accession number 26687.  
The chemical shift changes induced by Ca2+ binding to apoCaM12 occur for residues only in the C-
lobe. This lobe contains the EF hands not affected by mutation and thus still able to undergo the 
conformational change associated with binding Ca2+. The N-lobe residues show little chemical shift 
differences indicating a similar structure for the N-lobe in both proteins (Fig. 2B). A similar result is 
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found with Ca2+ binding to apoCaM34, however, in the opposite lobes (Fig. 2C). Tiny chemical shift 
differences are seen for the C-lobe and large chemical shift differences are seen for the N-lobe. 
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Table 1. Ca2+-deficient CaM mutants used in this study and completion of chemical shift assignments. 






Residues missinga BMRB # 
ApoCaM12 H, NH 97.9 N/Ab A1, D2, F92 26682 
ApoCaM34 H, NH 94.5 N/Ab A1, D2, R90, V91, 
F92, I100, V136, E140 
26683 
Ca2+CaM12 H, NH 97.9 N/Ab A1, D2, A57 26685 
Ca2+CaM34 H, NH 91.8 N/Ab A1, D2, E67, M72, 
R86, R90, V91, F92, 
A93, I100, V136, E140 
26686 
ApoCaM1234 H, NH, Cα, 
Cβ, Hα, Hβ, 
Hγ,  Hδ 
97.2 96.6 Cα, 90.5 
Cβ, 84.0 
sidechain H, 
96.6 Hα, 91.9 
Hβ  
A1, D2, R90, I100 26681 
Ca2+CaM34-
iNOS 
H, NH, Cα, 
Cβ, Cγ ,Cδ ,  
Hα, Hβ, Hγ,  
Hδ 
98.6 97.3 Cα, 96.4 
Cβ, 89.4 
sidechain H, 
97.3 Hα, 96.4 
Hβ  
A1, I100 26687 
aChemical shifts were not assigned for P43 or P66. 





Fig. 1  
(A) [1H,15N]-HSQC spectrum of CaM1234. (B) [1H,15N]-HSQC spectrum of CaM34 bound to the iNOS 
CaM binding domain peptide. Each backbone amide resonance is labeled with the amino acid type and 





 Chemical shift differences between: (A) ApoCaM and CaM1234; (B) Apo and Ca2+CaM12; (C) Apo 
and Ca2+CaM34; and (D) wt CaM−iNOS complex and CaM34−iNOS complex. The contribution of 1HN 
and 15N chemical shift changes for each residue was calculated as Δδ = √[( Δδ1HN)2 + (Δδ15N/5)2], 
where Δδ1HN and Δδ15N are the differences in 1HN and 15N chemical shifts between the indicated 
protein. The greatest differences are localized to Ca2+ binding loops where each mutation is present. 
